38
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Astragaloside IV synergizes with ferulic acid to inhibit renal tubulointerstitial fibrosis in rats with obstructive nephropathy

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          BACKGROUND AND PURPOSE

          The combination of Chinese herbs, Astragali Radix and Angelicae Sinensis Radix, could alleviate renal interstitial fibrosis. Astragaloside IV (AS-IV) and ferulic acid (FA) are the two major active constituents in this combination. In this study, we employed rats with unilateral ureteral obstruction to determine whether AS-IV and FA have the same renoprotective effects and investigated the mechanisms of this action.

          EXPERIMENTAL APPROACH

          Renal pathological changes were evaluated after treatment with AS-IV, FA or AS-IV + FA ( AF) for 10 days. Meanwhile, the expression of transforming growth factor β 1 (TGF-β 1), fibronectin, α-smooth muscle actin (α-SMA), phosphorylation of c-Jun NH 2-terminal kinase (p-JNK) and nitric oxide (NO) production in kidney were determined. The expressions of fibronectin, α-SMA, mitogen-activated protein kinases [JNK, extracellular signal-regulated kinases (ERK), P38] in TGF-β 1-treated NRK-49F cells or interleukin-1-treated HK-2 cells after AS-IV, FA or AF were assessed.

          KEY RESULTS

          AF alleviated the infiltration of mononuclear cells, tubular atrophy and interstitial fibrosis; reduced the expression of fibronectin, α-SMA, TGF-β 1 and p-JNK; and dramatically increased the production of NO in obstructed kidneys. Neither AS-IV nor FA alone improved renal damage, but both increased NO production. AF inhibited α-SMA and fibronectin expression in NRK-49F or HK-2 cells. Furthermore, AF significantly inhibited IL-1β-induced JNK phosphorylation, without affecting ERK or P38 phosphorylation. Neither AS-IV nor FA alone had any effect on the cells.

          CONCLUSIONS AND IMPLICATIONS

          AS-IV synergizes with FA to alleviate renal tubulointerstitial fibrosis; this was associated with inhibition of tubular epithelial–mesenchymal transdifferentiation (EMT) and fibroblast activation, as well as an increase in NO production in the kidney.

          Related collections

          Most cited references53

          • Record: found
          • Abstract: found
          • Article: not found

          Fibroblasts in kidney fibrosis emerge via endothelial-to-mesenchymal transition.

          Fibroblasts are key mediators of fibrosis in the kidney and other organs, but their origin during fibrosis is still not completely clear. Activated fibroblasts likely arise from resident quiescent fibroblasts via epithelial-to-mesenchymal transition and from the bone marrow. Here, we demonstrate that endothelial cells also contribute to the emergence of fibroblasts during kidney fibrosis via the process of endothelial-to-mesenchymal transition (EndMT). We examined the contribution of EndMT to renal fibrosis in three mouse models of chronic kidney disease: (1) Unilateral ureteral obstructive nephropathy, (2) streptozotocin-induced diabetic nephropathy, and (3) a model of Alport renal disease. Approximately 30 to 50% of fibroblasts coexpressed the endothelial marker CD31 and markers of fibroblasts and myofibroblasts such as fibroblast specific protein-1 and alpha-smooth muscle actin. Endothelial lineage tracing using Tie2-Cre;R26R-stop-EYFP transgenic mice further confirmed the presence of EndMT-derived fibroblasts. Collectively, our results demonstrate that EndMT contributes to the accumulation of activated fibroblasts and myofibroblasts in kidney fibrosis and suggest that targeting EndMT might have therapeutic potential.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            TGF-beta signaling in renal disease.

            Since discovery over a decade ago of a role for the cytokine TGF-beta as key mediator of glomerular and tubulointerstitial pathobiology in chronic kidney diseases, studies of TGF-beta signaling in the kidney have focused on the molecular biology of fibrogenesis. In recent years, glomerular and tubular epithelial cell apoptosis and cellular transdifferentiation have been proposed as putative primary pathomechanisms that may underlie progression of renal disease. This review describes evidence in support of nonlinear models and functional roles of TGF-beta signaling in mediating apoptosis and epithelial-to-mesenchymal transdifferentiation (EMT) in chronic progressive renal disease. Emphasis is placed on cell context-dependent models of TGF-beta signaling providing a conceptual framework to consolidate seemingly distinct pathomechanisms of progression of glomerular and tubulointerstitial disease.
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              Renal fibroblasts and myofibroblasts in chronic kidney disease.

                Bookmark

                Author and article information

                Journal
                Br J Pharmacol
                bph
                British Journal of Pharmacology
                Blackwell Publishing Ltd
                0007-1188
                1476-5381
                April 2011
                : 162
                : 8
                : 1805-1818
                Affiliations
                [1 ]simpleRenal Division, Department of Medicine, Peking University First Hospital; Peking University Institute of Nephrology; Key Laboratory of Renal Disease, Ministry of Health of China Beijing, China
                [2 ]simpleState Key Laboratory of Natural and Biomimetic Drugs, Peking University School of Pharmaceutical Sciences Beijing, China
                Author notes
                Professor Xiaomei Li, Renal Division, Department of Medicine, Peking University First Hospital, No. 8 Xishiku Street Xicheng District, Beijng China. E-mail: xiaomei0708@ 123456gmail.com

                Re-use of this article is permitted in accordance with the Terms and Conditions set out at http://wileyonlinelibrary.com/onlineopen#OnlineOpen_Terms

                Article
                10.1111/j.1476-5381.2011.01206.x
                3081123
                21232035
                c9bb1247-ac92-4b63-a1c6-95d63a1eb60c
                British Journal of Pharmacology © 2011 The British Pharmacological Society
                History
                : 27 June 2010
                : 28 November 2010
                : 01 December 2010
                Categories
                Research Papers

                Pharmacology & Pharmaceutical medicine
                mitogen-activated protein kinase,unilateral ureteral obstruction,rat,angelicae sinensis radix,astragaloside iv,ferulic acid,astragali radix,renal tubulointerstitial fibrosis

                Comments

                Comment on this article